A. Pellin et al., MOLECULAR ALTERATIONS OF THE RB1, TP53, AND MDM2 GENES IN PRIMARY ANDXENOGRAFTED HUMAN OSTEOSARCOMAS, Diagnostic molecular pathology, 6(6), 1997, pp. 333-341
We report the status of the RB1, TP53, and MDM2 genes in human osteosa
rcomas and cell lines established from surgical specimens and transpla
nted into athymic naked mice. By using reverse transcriptase-polymeras
e chain reaction (RT-FCR) as a prescreening technique and posterior se
quencing, we observe new mutations in the RB1 gene, notably a duplicat
ion in tan dem of exons 3 through 6. TP53 mutations appear in codons m
ost frequently mutated in osteosarcomas. We have not seer MDM2 gene am
plification in any reported case. These molecular alterations appear i
n different osteosarcomas not simultaneously present in the same tumor
sample. A link has been described between these three genes in the pa
thways that control the cell cycle and the tumoral progression, but th
eir functions are probably independent in the development of osteosarc
omas. TP53 mutations appear in adult patients, whereas RB1 alterations
occur mostly in younger patients.